Physician profile
Stephen Robert Wells
NPI 1659385151
$4,217.92
in general payments reported to CMS, 2019-2025
33 companies · $713 in 2025
The $713 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $735 · 2020: $201 · 2021: $471 · 2022: $586 · 2023: $802 · 2024: $711 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,206 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,205.50 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,363.84 | 2019-2025 | Lo Loestrin Fe, Liletta, Orilissa |
| Astellas Pharma US INC | $330.12 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $327.82 | 2021-2025 | |
| Intuitive Surgical, INC. | $278.36 | 2019 | |
| Therapeuticsmd, INC. | $217.70 | 2019-2022 | |
| Organon LLC | $208.03 | 2021-2025 | Nexplanon |
| Biogen, INC. | $164.74 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $155.56 | 2020-2022 | |
| Hologic Sales and Service, LLC | $133.05 | 2020-2025 | Novasure |
| Vertical Pharmaceuticals, LLC | $128.53 | 2019 | |
| Pfizer INC. | $114.60 | 2021-2025 | |
| Coopersurgical, INC. | $96.01 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Avion Pharmaceuticals | $94.73 | 2021 | |
| Exeltis, USA INC. | $65.38 | 2025 | Slynd |
| Evofem Biosciences, INC. | $51.27 | 2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $46.05 | 2019-2020 | |
| Exact Sciences Corporation | $42.95 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $40.22 | 2023-2024 | Gardasil 9, Gardasil |
| Myovant Sciences INC. | $38.53 | 2021-2022 | |
| Agile Therapeutics, INC. | $35.71 | 2022-2024 | Twirla |
| Dexcom, INC. | $33.48 | 2025 | Dexcom G6 Transmitter |
| Meditrina | $29.23 | 2022-2025 | |
| Becton, Dickinson and Company | $23.73 | 2024 | |
| Roche Diagnostics Corporation | $23.38 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.61 | 2023 | |
| Mimedx Group, INC. | $22.25 | 2025 | |
| Sumitomo Pharma America, INC. | $22.18 | 2023 | Myfembree |
| Minerva Surgical, INC | $21.24 | 2023 | |
| Aspira Women'S Health INC | $20.85 | 2022 | |
| Ascend Therapeutics US, LLC | $19.86 | 2024 | |
| Avanos Medical | $18.26 | 2022 | |
| Dysis Medical, INC. | $14.07 | 2022 | |
| Lupin INC. | $13.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.